News | Artificial Intelligence | November 28, 2021

 

With its most mature product--Lunit INSIGHT CXR and Lunit INSIGHT MMG--now clinically used in more than 30 countries, the company expands its AI product line for radiology Lunit INSIGHT to DBT and chest CT

Demo of Lunit INSIGHT DBT and Lunit INSIGHT Chest CT are introduced at Lunit booth #4545, with the official launch expected next year 

Including product demonstration at its booth, the company also take parts in 13 abstract presentation and CEO speech at AI Theater


November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) this year with its up-to-date, comprehensive AI solutions for chest and breast radiology. Along with its most mature products, the company will showcase the demo version of the brand-new AI solution for digital breast tomosynthesis (DBT) and chest CT in its booth #4545, RSNA South Hall.

Lunit’s most mature products for radiology include AI solutions for chest x-ray, Lunit INSIGHT CXR and for mammography, Lunit INSIGHT MMG, which have been first introduced at RSNA 2017 and 2018 respectively. The company has been presenting the upgraded versions of the software ever since, now clinically available in 400 medical sites in more than 30 countries. This time the company is expanding Lunit INSIGHT product lines with DBT and chest CT solutions.

According to the company, its AI solution for DBT is called ‘Lunit INSIGHT DBT’, which can accelerate reading by handpicking the 3D slice image with suspicious lesions among multiple images. Its solution for CT is ‘Lunit INSIGHT Chest CT’, which AI automatically generates the location, type, volume, and axial diameter of the detected nodule. 

“Chest x-ray and mammography are the first-line examinations where you find suspicious diseases that can cause lung or breast cancer,” said Sunggyun Park, Chief Product Officer of Lunit. “CT and DBT are more sophisticated examinations where you can further evaluate the specification of nodules or distinguish cancer. At this stage, our AI will be able to assist radiologists to diagnose cancer faster, at a higher accuracy. The products are now under final validation and expected to officially launch next year.”

“It is meaningful for us to introduce the demo of Lunit INSIGHT DBT and Lunit INSIGHT Chest CT for the first time at this year’s RSNA, where we can actually demonstrate the solution to our potential users,” said Brandon Suh, CEO of Lunit. “From x-ray, mammography to Chest CT, DBT and more, we will keep working on developing innovative AI solutions to offer comprehensive medical imaging--to improve radiologist workflow and patient health.”

Lunit at RSNA 2021

Lunit Booth

Visit booth #4545 South Hall for product demonstration for Lunit INSIGHT CXR, Lunit INSIGHT MMG, Lunit INSIGHT DBT and Lunit INSIGHT Chest CT. Available from Nov. 28 – Dec. 2, 2021, 10 a.m. to 5 p.m. daily

Some of the products will be available for demonstration during RSNA, not only at Lunit booth, but also displayed at our global partners’ booths: FUJIFILM, GE Healthcare, Philips, INFINITT healthcare and SECTRA.

CEO Presentation at AI Theater

Lunit’s CEO, Brandon Suh, will be on stage at AI Theater to give an industry presentation about the recent and upcoming product developments, business activities on how our AI is clinically applied across global sites.

Title: Perfecting Intelligence, Transforming Medicine: A.I. in Lung and Breast Diagnostics


When: Sunday, Nov. 28 2:30 - 2:45 p.m. CDT


Session ID: IS9-AI109

If you would like to book a media interview with our CEO, contact [email protected].

Presenting 13 Abstracts

Studies on the diagnostic value of AI in chest and breast radiology will be presented during the event. Abstracts include the effectiveness of AI in finding breast cancer on DBT analysis, clinical validation of Lunit INSIGHT CXR and Lunit INSIGHT MMG and more. 

Search “Lunit” in RSNA meeting program to read our abstracts.

Book your meeting with Lunit at RSNA 2021 live or virtually

Related Content

News | Digital Radiography (DR)

January 25, 2022 — Carestream Health was awarded 45 new patents in 2021 for global advances in artificial intelligence ...

Time January 26, 2022
arrow
News | Radiology Education

January 25, 2022 — Technical Prospects, a leader in the medical imaging industry, has announced the launch of its BioMed ...

Time January 25, 2022
arrow
Sponsored Content | Videos | Magnetic Resonance Imaging (MRI)

With the recent launch of the Magnifico Open, Italian company Esaote has entered the open MRI whole body space. ITN had ...

Time January 24, 2022
arrow
News | Radiology Business

January 21, 2022 — IBM and Francisco Partners, a leading global investment firm that specializes in partnering with ...

Time January 21, 2022
arrow
Sponsored Content | Case Study | Computed Tomography (CT)

Approximately thirteen men out of every 100 will get prostate cancer during their lifetime, and about two to three men ...

Time January 21, 2022
arrow
Feature | Breast Imaging | By Bhvita Jani

The rising global incidence rates of breast cancer, coupled with the severe backlog of women requiring breast cancer ...

Time January 20, 2022
arrow
News | Artificial Intelligence

January 20, 2022 — Leading health tech firm Qure.ai has gained 510(k) clearance from the Food and Drug Administration ...

Time January 20, 2022
arrow
Feature | Vendor Neutral Archive (VNA)

Vendor neutral archives (VNAs) have become a staple within the healthcare IT system. At the Radiological Society of ...

Time January 20, 2022
arrow
Feature | Radiology Business | By Jef Williams

The Great Resignation has impacted every industry, including ours. While this movement will be studied for years to come ...

Time January 20, 2022
arrow
Feature | Artificial Intelligence | By Dave Fornell, ITN Editor

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

Time January 19, 2022
arrow
Subscribe Now